Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cystic Fibrosis | 21 | 2018 | 1104 | 4.02 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 8 | 2018 | 113 | 1.63 | Why? |
| Chloride Channel Agonists | 4 | 2018 | 10 | 1.34 | Why? |
| Aminophenols | 4 | 2018 | 22 | 1.24 | Why? |
| Receptors, Interleukin-1 | 2 | 2017 | 161 | 0.78 | Why? |
| Mucus | 2 | 2018 | 183 | 0.74 | Why? |
| Lung Diseases, Obstructive | 1 | 2018 | 46 | 0.74 | Why? |
| Lung Diseases | 5 | 2018 | 2361 | 0.71 | Why? |
| Hemangioma, Capillary | 1 | 2017 | 17 | 0.68 | Why? |
| Bronchial Neoplasms | 1 | 2017 | 18 | 0.67 | Why? |
| Ion Channels | 1 | 2018 | 167 | 0.64 | Why? |
| Quinolones | 4 | 2018 | 167 | 0.63 | Why? |
| Airway Remodeling | 1 | 2017 | 111 | 0.63 | Why? |
| Trypsinogen | 1 | 2015 | 4 | 0.62 | Why? |
| Interferon Regulatory Factor-1 | 1 | 2014 | 33 | 0.57 | Why? |
| Hemoptysis | 1 | 2017 | 172 | 0.54 | Why? |
| Benzodioxoles | 3 | 2018 | 78 | 0.52 | Why? |
| Cathepsins | 1 | 2014 | 204 | 0.52 | Why? |
| Antigens, Neoplasm | 1 | 2015 | 230 | 0.51 | Why? |
| Sputum | 2 | 2018 | 1720 | 0.49 | Why? |
| Lectins, C-Type | 1 | 2015 | 405 | 0.47 | Why? |
| Neonatal Screening | 1 | 2015 | 285 | 0.46 | Why? |
| Respiratory Mucosa | 4 | 2018 | 1522 | 0.43 | Why? |
| Tetracycline | 1 | 2010 | 33 | 0.42 | Why? |
| Magnetic Resonance Imaging | 5 | 2018 | 6551 | 0.39 | Why? |
| Trans-Activators | 1 | 2010 | 170 | 0.37 | Why? |
| Lung | 10 | 2018 | 31049 | 0.36 | Why? |
| Leukocyte Elastase | 2 | 2018 | 106 | 0.34 | Why? |
| Aminopyridines | 2 | 2018 | 121 | 0.34 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 2309 | 0.31 | Why? |
| Biomarkers, Tumor | 1 | 2015 | 1314 | 0.30 | Why? |
| Neutrophils | 3 | 2018 | 5476 | 0.28 | Why? |
| Berlin | 5 | 2021 | 283 | 0.27 | Why? |
| Pseudomonas Infections | 2 | 2018 | 425 | 0.25 | Why? |
| Pseudomonas aeruginosa | 2 | 2018 | 652 | 0.24 | Why? |
| Anoctamin-1 | 2 | 2018 | 4 | 0.24 | Why? |
| Respiratory Function Tests | 3 | 2018 | 1755 | 0.23 | Why? |
| Epithelium | 3 | 2018 | 330 | 0.22 | Why? |
| MicroRNAs | 1 | 2014 | 1787 | 0.22 | Why? |
| Epithelial Sodium Channels | 2 | 2018 | 41 | 0.22 | Why? |
| Inflammation | 3 | 2018 | 13255 | 0.20 | Why? |
| Polyendocrinopathies, Autoimmune | 1 | 2021 | 129 | 0.20 | Why? |
| Indoles | 2 | 2018 | 1243 | 0.20 | Why? |
| Vascular Ring | 1 | 2018 | 3 | 0.20 | Why? |
| Germany | 7 | 2021 | 9196 | 0.20 | Why? |
| Gene Expression | 1 | 2010 | 3332 | 0.19 | Why? |
| Transforming Growth Factor beta | 1 | 2021 | 363 | 0.18 | Why? |
| Chloride Channels | 1 | 2018 | 51 | 0.18 | Why? |
| Interleukin-1alpha | 1 | 2018 | 42 | 0.18 | Why? |
| Expectorants | 1 | 2018 | 95 | 0.18 | Why? |
| Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 48 | 0.18 | Why? |
| Introns | 1 | 2017 | 112 | 0.18 | Why? |
| Feasibility Studies | 2 | 2018 | 3467 | 0.18 | Why? |
| Oligonucleotides | 1 | 2018 | 137 | 0.18 | Why? |
| Inhalation | 1 | 2018 | 86 | 0.17 | Why? |
| Oligonucleotides, Antisense | 1 | 2018 | 111 | 0.17 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2017 | 27 | 0.17 | Why? |
| Isotopes | 1 | 2016 | 20 | 0.17 | Why? |
| DNA Repair | 1 | 2017 | 114 | 0.17 | Why? |
| Helium | 1 | 2016 | 21 | 0.17 | Why? |
| Mucins | 1 | 2018 | 147 | 0.17 | Why? |
| Cation Transport Proteins | 1 | 2017 | 53 | 0.17 | Why? |
| Microsatellite Repeats | 1 | 2017 | 99 | 0.17 | Why? |
| Peroxidase | 1 | 2018 | 207 | 0.17 | Why? |
| Hepcidins | 1 | 2017 | 97 | 0.16 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2017 | 100 | 0.16 | Why? |
| Matrix Metalloproteinases | 1 | 2017 | 131 | 0.16 | Why? |
| Radiation Exposure | 1 | 2018 | 161 | 0.15 | Why? |
| Pancreatitis-Associated Proteins | 1 | 2015 | 5 | 0.15 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.15 | Why? |
| Iron Overload | 1 | 2017 | 113 | 0.15 | Why? |
| Multidetector Computed Tomography | 1 | 2018 | 307 | 0.14 | Why? |
| Spirometry | 1 | 2018 | 524 | 0.14 | Why? |
| Pyrrolidines | 1 | 2018 | 558 | 0.14 | Why? |
| Exhalation | 1 | 2018 | 441 | 0.14 | Why? |
| Drug Combinations | 3 | 2018 | 3852 | 0.13 | Why? |
| Breath Tests | 1 | 2017 | 338 | 0.13 | Why? |
| Reference Standards | 1 | 2018 | 1163 | 0.13 | Why? |
| Bronchi | 2 | 2018 | 1048 | 0.13 | Why? |
| Mice, Inbred C57BL | 5 | 2018 | 5542 | 0.13 | Why? |
| Calcium | 1 | 2018 | 708 | 0.12 | Why? |
| Infant | 5 | 2018 | 30274 | 0.12 | Why? |
| Interleukin-8 | 1 | 2018 | 964 | 0.12 | Why? |
| Pulmonary Alveoli | 1 | 2017 | 867 | 0.11 | Why? |
| Mice, Transgenic | 3 | 2017 | 2739 | 0.11 | Why? |
| Iron | 1 | 2017 | 619 | 0.11 | Why? |
| Humans | 37 | 2021 | 930598 | 0.11 | Why? |
| Uteroglobin | 1 | 2010 | 10 | 0.11 | Why? |
| Integrases | 1 | 2010 | 17 | 0.11 | Why? |
| Signal Transduction | 5 | 2018 | 7207 | 0.11 | Why? |
| Genetic Techniques | 1 | 2010 | 79 | 0.10 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.10 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.10 | Why? |
| Animals, Newborn | 1 | 2010 | 350 | 0.10 | Why? |
| Heart Defects, Congenital | 1 | 2018 | 933 | 0.09 | Why? |
| Ion Transport | 2 | 2018 | 43 | 0.09 | Why? |
| Bronchoscopy | 1 | 2017 | 991 | 0.09 | Why? |
| Chlorides | 2 | 2018 | 82 | 0.09 | Why? |
| Child, Preschool | 5 | 2018 | 36283 | 0.09 | Why? |
| Mice | 7 | 2018 | 21357 | 0.09 | Why? |
| Thorax | 1 | 2018 | 1873 | 0.09 | Why? |
| Female | 20 | 2021 | 380317 | 0.09 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.09 | Why? |
| Pyrazoles | 1 | 2018 | 1791 | 0.09 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.09 | Why? |
| Doxycycline | 1 | 2010 | 307 | 0.08 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.08 | Why? |
| Animals | 11 | 2018 | 78931 | 0.08 | Why? |
| Male | 18 | 2021 | 367725 | 0.08 | Why? |
| Promoter Regions, Genetic | 1 | 2010 | 823 | 0.08 | Why? |
| Organ Specificity | 1 | 2010 | 1070 | 0.07 | Why? |
| Chronic Disease | 2 | 2018 | 5139 | 0.07 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.07 | Why? |
| Forced Expiratory Volume | 2 | 2018 | 632 | 0.07 | Why? |
| Respiratory System | 1 | 2018 | 3213 | 0.07 | Why? |
| Mutation | 3 | 2018 | 12376 | 0.06 | Why? |
| Dyspnea | 1 | 2017 | 3847 | 0.06 | Why? |
| Trachea | 2 | 2018 | 894 | 0.06 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.06 | Why? |
| Cough | 1 | 2017 | 4891 | 0.06 | Why? |
| Tomography, X-Ray Computed | 3 | 2018 | 25144 | 0.06 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.06 | Why? |
| Rats | 1 | 2010 | 2764 | 0.06 | Why? |
| Hypoxia | 1 | 2017 | 3626 | 0.06 | Why? |
| Child | 7 | 2021 | 70012 | 0.06 | Why? |
| Day Care, Medical | 1 | 2021 | 117 | 0.05 | Why? |
| CD3 Complex | 1 | 2021 | 237 | 0.05 | Why? |
| Dose-Response Relationship, Drug | 1 | 2010 | 3776 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Patient Acuity | 2 | 2018 | 1755 | 0.05 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.05 | Why? |
| Tracheobronchomalacia | 1 | 2018 | 1 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.05 | Why? |
| Bronchial Diseases | 1 | 2018 | 31 | 0.05 | Why? |
| MRE11 Homologue Protein | 1 | 2017 | 1 | 0.05 | Why? |
| Antiporters | 1 | 2017 | 11 | 0.05 | Why? |
| DNA Breaks, Double-Stranded | 1 | 2017 | 17 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.04 | Why? |
| Mice, Inbred C3H | 1 | 2017 | 102 | 0.04 | Why? |
| Microbial Consortia | 1 | 2017 | 20 | 0.04 | Why? |
| Lung Volume Measurements | 1 | 2018 | 115 | 0.04 | Why? |
| Adult | 10 | 2021 | 244371 | 0.04 | Why? |
| DNA Repair Enzymes | 1 | 2017 | 33 | 0.04 | Why? |
| Plasma Cells | 1 | 2021 | 464 | 0.04 | Why? |
| Sweat | 1 | 2018 | 127 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2021 | 1027 | 0.04 | Why? |
| Phenotype | 2 | 2020 | 4037 | 0.04 | Why? |
| Microbial Interactions | 1 | 2017 | 67 | 0.04 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.04 | Why? |
| Tracheal Stenosis | 1 | 2018 | 80 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Diffusion | 1 | 2017 | 73 | 0.04 | Why? |
| Homozygote | 1 | 2018 | 230 | 0.04 | Why? |
| X-Ray Microtomography | 1 | 2017 | 115 | 0.04 | Why? |
| Lipid Peroxidation | 1 | 2017 | 114 | 0.04 | Why? |
| Esophagus | 1 | 2018 | 139 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2021 | 813 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Reperfusion Injury | 1 | 2017 | 178 | 0.04 | Why? |
| Automation | 1 | 2018 | 429 | 0.04 | Why? |
| Transcription Factors | 1 | 2021 | 784 | 0.04 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.04 | Why? |
| Interleukins | 1 | 2021 | 762 | 0.04 | Why? |
| Schools | 2 | 2021 | 4187 | 0.04 | Why? |
| Cell Nucleus | 1 | 2017 | 399 | 0.04 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.03 | Why? |
| Coronavirus NL63, Human | 1 | 2020 | 669 | 0.03 | Why? |
| Cellular Senescence | 1 | 2017 | 326 | 0.03 | Why? |
| Sensitivity and Specificity | 1 | 2015 | 22971 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.03 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Macrophages, Alveolar | 1 | 2017 | 668 | 0.03 | Why? |
| Proteolysis | 1 | 2017 | 751 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2020 | 1887 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Bronchiectasis | 1 | 2017 | 312 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2020 | 1157 | 0.03 | Why? |
| Coronavirus 229E, Human | 1 | 2020 | 1241 | 0.03 | Why? |
| DNA | 1 | 2017 | 778 | 0.03 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Cohort Studies | 1 | 2015 | 36005 | 0.03 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Pharynx | 1 | 2018 | 1544 | 0.03 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.03 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Perception | 1 | 2021 | 2827 | 0.02 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Outpatients | 1 | 2021 | 3417 | 0.02 | Why? |
| Pulmonary Fibrosis | 1 | 2017 | 1068 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.02 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.02 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Protease Inhibitors | 1 | 2017 | 3630 | 0.01 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |